14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of RANI
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

High volatility in Rani Therapeutics Holdings, Inc. stock price on Friday which ended trading at $5.22
(Updated on May 17, 2024)

Sell candidate since May 15, 2024 Loss -5.61% PDF

The Rani Therapeutics Holdings, Inc. stock price fell by -4.40% on the last day (Friday, 17th May 2024) from $5.46 to $5.22. It has now fallen 9 days in a row. During the last trading day the stock fluctuated 14.47% from a day low at $5.01 to a day high of $5.74. The price has fallen in 9 of the last 10 days and is down by -26.99% for this period. Volume has increased on the last day by 37 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 114 thousand shares were bought and sold for approximately $594.25 thousand.

Given the current short-term trend, the stock is expected to rise 84.71% during the next 3 months and, with a 90% probability hold a price between $9.64 and $17.32 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

RANI Signals & Forecast

There are few to no technical positive signals at the moment. The Rani Therapeutics Holdings, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $5.88 and $5.78. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, April 17, 2024, and so far it has fallen -33.50%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Rani Therapeutics Holdings, Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Rani Therapeutics Holdings, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $4.47 and $4.16. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Rani Therapeutics Holdings, Inc. finds support just below today's level at $4.47. If this is broken, then the next support from accumulated volume will be at $4.16 and $4.00.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.725 between high and low, or 14.47%. For the last week, the stock has had daily average volatility of 10.83%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (RANI) For The Upcoming Trading Day Of Monday 20th

For the upcoming trading day on Monday, 20th we expect Rani Therapeutics Holdings, Inc. to open at $5.32, and during the day (based on 14 day Average True Range), to move between $4.56 and $5.88, which gives a possible trading interval of +/-$0.659 (+/-12.63%) up or down from last closing price. If Rani Therapeutics Holdings, Inc. takes out the full calculated possible swing range there will be an estimated 25.25% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $5.40 (3.45%) than the support at $4.47 (14.37%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Rani Therapeutics Holdings, Inc. stock A Buy?

The Rani Therapeutics Holdings, Inc. stock holds several negative signals and despite the positive trend, we believe Rani Therapeutics Holdings, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -5.031 Strong Sell Candidate Unchanged

Predicted Opening Price for Rani Therapeutics Holdings, Inc. of Monday, May 20, 2024

Fair opening price May 20, 2024 Current price
$5.32 ( 1.95%) $5.22

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for RANI

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 6.05 15.84 %
R2 5.77 10.53 %
R1 5.60 7.25 %
Current price: 5.22
Support S1 5.04 -3.36 %
S2 4.87 -6.64 %
S3 4.60 -11.94 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 6.37 22.03 %
R2 6.05 15.90 %
R1 5.40 3.45 %
Current price 5.22
Support S1 4.47 -14.37%
S2 4.16 -20.31%
S3 4.00 -23.37%

FAQ

What is the symbol for Rani Therapeutics Holdings, Inc. Stock and on which exchange is it traded?
The symbol for Rani Therapeutics Holdings, Inc. is RANI and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Rani Therapeutics Holdings, Inc. Stock?
The Rani Therapeutics Holdings, Inc. stock holds several negative signals and despite the positive trend, we believe Rani Therapeutics Holdings, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Rani Therapeutics Holdings, Inc. Stock?
Rani Therapeutics Holdings, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Rani Therapeutics Holdings, Inc. Stock.

What's the current price of Rani Therapeutics Holdings, Inc. Stock?
As of the end of day on the May 17, 2024, the price of an Rani Therapeutics Holdings, Inc. (RANI) share was $5.22.

What is the 52-week high and low for Rani Therapeutics Holdings, Inc. Stock?
The 52-week high for Rani Therapeutics Holdings, Inc. Stock is $8.75 and the 52-week low is $1.82.

What is the market capitalization of Rani Therapeutics Holdings, Inc. Stock?
As of the May 17, 2024, the market capitalization of Rani Therapeutics Holdings, Inc. is 275.263M.

When is the next earnings date for Rani Therapeutics Holdings, Inc.?
The upcoming earnings date for Rani Therapeutics Holdings, Inc. is Aug 09, 2024.
Click to get the best stock tips daily for free!

About Rani Therapeutics Holdings, Inc.

Rani Therapeutics Holdings. Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed Phase I clinical trial for the treatment of neuroendocrine tumors and acromegaly; RT-105, an anti-TNF-al... RANI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT